Johnson & Johnson Price to Free Cash Flow Ratio 2006-2018 | JNJ
Historical price to free cash flow ratio values for Johnson & Johnson (JNJ) since 2006.
| Johnson & Johnson Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2019-02-22 |
136.60 |
|
8.10 |
| 2018-09-30 |
137.30 |
$16.86 |
8.14 |
| 2018-06-30 |
119.77 |
$16.53 |
7.25 |
| 2018-03-31 |
125.57 |
$15.97 |
7.86 |
| 2017-12-31 |
136.04 |
$15.75 |
8.64 |
| 2017-09-30 |
125.82 |
$14.63 |
8.60 |
| 2017-06-30 |
127.21 |
$13.55 |
9.39 |
| 2017-03-31 |
118.99 |
$12.95 |
9.19 |
| 2016-12-31 |
109.35 |
$12.65 |
8.65 |
| 2016-09-30 |
111.35 |
$13.58 |
8.20 |
| 2016-06-30 |
113.58 |
$14.67 |
7.74 |
| 2016-03-31 |
100.60 |
$15.44 |
6.52 |
| 2015-12-31 |
94.82 |
$15.74 |
6.03 |
| 2015-09-30 |
85.55 |
$15.63 |
5.47 |
| 2015-06-30 |
88.62 |
$16.36 |
5.42 |
| 2015-03-31 |
90.81 |
$16.41 |
5.53 |
| 2014-12-31 |
93.74 |
$16.70 |
5.61 |
| 2014-09-30 |
94.93 |
$14.81 |
6.41 |
| 2014-06-30 |
92.55 |
$13.02 |
7.11 |
| 2014-03-31 |
86.30 |
$12.16 |
7.10 |
| 2013-12-31 |
79.89 |
$11.63 |
6.87 |
| 2013-09-30 |
75.09 |
$11.63 |
6.46 |
| 2013-06-30 |
73.82 |
$11.66 |
6.33 |
| 2013-03-31 |
69.57 |
$11.92 |
5.84 |
| 2012-12-31 |
59.34 |
$12.25 |
4.85 |
| 2012-09-30 |
57.83 |
$11.87 |
4.87 |
| 2012-06-30 |
56.19 |
$11.45 |
4.91 |
| 2012-03-31 |
54.33 |
$10.99 |
4.95 |
| 2011-12-31 |
53.55 |
$10.75 |
4.98 |
| 2011-09-30 |
51.53 |
$11.37 |
4.53 |
| 2011-06-30 |
53.34 |
$11.95 |
4.46 |
| 2011-03-31 |
47.10 |
$12.45 |
3.78 |
| 2010-12-31 |
48.73 |
$12.95 |
3.76 |
| 2010-09-30 |
48.40 |
$12.89 |
3.76 |
| 2010-06-30 |
45.70 |
$12.27 |
3.72 |
| 2010-03-31 |
50.00 |
$11.73 |
4.26 |
| 2009-12-31 |
49.01 |
$11.38 |
4.31 |
| 2009-09-30 |
45.97 |
$10.70 |
4.29 |
| 2009-06-30 |
42.54 |
$10.41 |
4.08 |
| 2009-03-31 |
39.05 |
$10.29 |
3.80 |
| 2008-12-31 |
44.05 |
$10.40 |
4.23 |
| 2008-09-30 |
50.60 |
$10.23 |
4.94 |
| 2008-06-30 |
46.70 |
$10.26 |
4.55 |
| 2008-03-31 |
46.75 |
$10.54 |
4.44 |
| 2007-12-31 |
47.76 |
$10.80 |
4.42 |
| 2007-09-30 |
46.75 |
$10.58 |
4.42 |
| 2007-06-30 |
43.56 |
$10.17 |
4.28 |
| 2007-03-31 |
42.32 |
$9.77 |
4.33 |
| 2006-12-31 |
46.09 |
$9.54 |
4.83 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$365.814B |
$81.581B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
